Conmed Names Gallagher, Succeeding Garner

Dow Jones
06/18

By Grace Yoon

Conmed appointed John Gallagher as chief financial officer, effective July 15.

Gallagher will succeed Todd Garner, who will remain with the medical technology company as an adviser through November 2.

Gallagher has three decades of financial experience, most recently serving as CFO of Certara, a pharmaceutical technology company. Prior to Certara, he was CFO of Cue Health and held other finance roles at Becton Dickinson, the Conmed said Wednesday.

Certara on Wednesday said that Gallagher was resigning, effective July 14.

Write to Grace Yoon at grace.yoon@wsj.com

 

(MORE TO FOLLOW) Dow Jones Newswires

June 17, 2026 16:59 ET (20:59 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10